Dietary flavonoids sensitize HeLa cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

Ewelina Szliszka1, Zenon P Czuba1, Katarzyna Jernas1

  • 1Chair and Department of Microbiology and Immunology, Jordana 19, 41 808 Zabrze.

Insights

Certain dietary flavonoids, like flavone, apigenin, and genistein, enhance the cancer-killing effects of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) in HeLa cells, suggesting potential for new cancer therapies.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a potential cancer therapeutic agent.
  • Flavonoids are natural compounds with potential chemopreventive and therapeutic properties.
  • Combining TRAIL with other agents may enhance its efficacy against malignant tumors.

Purpose of the Study:

  • To investigate the combined cytotoxic effects of dietary flavonoids and TRAIL on HeLa cancer cells.
  • To identify specific flavonoids that sensitize cancer cells to TRAIL-induced apoptosis.
  • To explore the potential of flavonoid-TRAIL combinations as a novel cancer therapy.

Main Methods:

  • HeLa cells were treated with noncytotoxic concentrations of various dietary flavonoids.
  • The cytotoxic effect of TRAIL was assessed in combination with these flavonoids.
  • Cell viability and apoptosis induction were measured to determine the combined effects.

Main Results:

  • Noncytotoxic concentrations of flavone, apigenin, and genistein significantly sensitized HeLa cells to TRAIL-induced death.
  • These specific flavonoids markedly augmented TRAIL-mediated cytotoxicity.
  • Kaempferol and quercetin did not produce a significant sensitizing effect in combination with TRAIL.

Conclusions:

  • Flavone, apigenin, and genistein show promise in enhancing TRAIL-based cancer therapy.
  • The combination of specific flavonoids with TRAIL could be a viable strategy for chemoprevention or treatment of malignant tumors.
  • Further research into flavonoid-TRAIL synergy may lead to new therapeutic approaches for cervical cancer.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...